| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/28/2002 | US20020038463 Methods for screening and identifying host pathogen defense genes |
| 03/28/2002 | US20020038185 Method for indicating relationship between cDNA sequence and genome recording medium, sequencer apparatus, and method for designing a primer |
| 03/28/2002 | US20020038016 Decoy probes |
| 03/28/2002 | US20020038015 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 03/28/2002 | US20020038013 Can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of physiological disorders |
| 03/28/2002 | US20020038012 Can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of physiological disorders |
| 03/28/2002 | US20020038011 Novel human kinases and polynucleotides encoding the same |
| 03/28/2002 | US20020038010 Novel human lysozymes and polynucleotides encoding the same |
| 03/28/2002 | US20020038009 Novel human kinase protein and polynucleotides encoding the same |
| 03/28/2002 | US20020038008 Utilized for microbiologic industry, such as breeding L-serine producing coryneform bacteria |
| 03/28/2002 | US20020038005 For using the genes, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance |
| 03/28/2002 | US20020038003 Novel antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2002 | US20020038001 Sesquiterpene synthases from grand fir (abies grandis), and methods of use |
| 03/28/2002 | US20020038000 Systematic polypeptide evolution by reverse translation |
| 03/28/2002 | US20020037999 Coiled-coil mediated heterodimerization functional interaction trap |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037996 The peptides can impart photoreactivity to a protein by binding to a non-heme iron |
| 03/28/2002 | US20020037920 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 03/28/2002 | US20020037870 Method of inhibiting cancer cell growth using a vector expressing pRb2/p130 |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037867 Administering into muscle of mammals |
| 03/28/2002 | US20020037866 Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037847 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037836 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/28/2002 | US20020037834 Process control; low temperature |
| 03/28/2002 | US20020037827 Genetic engineering |
| 03/28/2002 | US20020037587 Regulatory sequences for use as tools in genetic engineering |
| 03/28/2002 | US20020037582 Potential effector for the grb7 family of signalling proteins |
| 03/28/2002 | US20020037576 Method of producing infectious reovirus |
| 03/28/2002 | US20020037575 Recombinant virus vectors |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037573 Enzymatic protein for use in the generation of preferential protein complex |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037568 Nucleotide sequences which code for the mdhA gene |
| 03/28/2002 | US20020037567 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of collagen defects |
| 03/28/2002 | US20020037562 By cultivating a bacterium harboring a DNA coding for actohydroxy acid synthase isozime III originating from Escherichia coli which is free from inhibition by L-valine and has specified other properties; DNA |
| 03/28/2002 | US20020037558 Generating genetically engineered antibodies from prokaryotes; provide prokaryote, transform, culture cells, recover genetically engineered antibodies |
| 03/28/2002 | US20020037557 Nucleotide sequences which code proteins for use in the treatment of nervous system, cardiovascular and liver disorders; for use in treatment of burns, traumatic injuries, surgery and ulcers |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037552 Methods and cells for expression of recombinant protein products under the transcriptional control of an inducible promoter |
| 03/28/2002 | US20020037550 Molecular cloning of a mouse seven transmembrane receptor (AXOR70) |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037547 Process for the fermentative production of deacylated cephalosporins |
| 03/28/2002 | US20020037538 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 03/28/2002 | US20020037537 Measuring activity of endothelial growth factor modulator; obtain modulator, incubate with kinase, isolate phosphorylated substrate, remove label, detecting adjustment in kinase activity |
| 03/28/2002 | US20020037525 Method for generating transcriptionally active DNA fragments |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037522 Protein; for use in the prevention of antibiotic resistance in cancer therapy |
| 03/28/2002 | US20020037521 Method of identifying the source of genetic information in DNA |
| 03/28/2002 | US20020037519 Detecting protein binding positions in nucleotide sequences; obtain sequence, evaluate and compare to control binding sequences in libraries, determine binding positions |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | US20020037513 Nucleotide sequences coding enzymatic polypeptides for use in the diagnosis and treatment of cell proliferation and nervous system disorders |
| 03/28/2002 | US20020037512 Comprising a solution of a divalent metal chelator,,e.g. EDTA, and a chelator promoter consisting of lithium chloride, guanidine, sodium salicylate, sodium perchlorate or sodium thiocyanate; synergistic; medical diagnosis; gonorrhea |
| 03/28/2002 | US20020037511 Method for identifying genes |
| 03/28/2002 | US20020037510 Amplification and other enzymatic reactions performed on nucleic acid arrays |
| 03/28/2002 | US20020037509 Polymer coated surfaces for microarray applications |
| 03/28/2002 | US20020037505 Sequence based screening |
| 03/28/2002 | US20020037504 Method for preoparing template DNA from processed vegetable food, which is feasible for amplification of DNA region by PCR method |
| 03/28/2002 | US20020037500 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 03/28/2002 | US20020037499 Integrated active flux microfluidic devices and methods |
| 03/28/2002 | US20020037497 Suppressing viral activity in virally infected cells; obtain cells, incubate with viricide, monitoring cell inhibition enzyme activity |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037292 Avian polynucleotide vaccine formula |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
| 03/28/2002 | US20020037282 Universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 03/28/2002 | US20020037281 Methods of transducing neural cells using lentivirus vectors |
| 03/28/2002 | US20020037280 Useful for regulating transgene expression in cells such as tumor cells and therefore, for therapy of a variety of cancers |
| 03/28/2002 | US20020037274 Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | US20020036169 Matched Ion Polynucleotide Chromatography separation particles; contacting surfaces are material which does not release multivalent cations into aqueous solutions held therein or flowing therethrough |
| 03/28/2002 | DE10140095A1 New tmk gene of Coryneform bacteria, useful when suppressed, for increasing fermentative production of L-amino acids, encodes a thymidylate kinase |
| 03/28/2002 | DE10135996A1 Identifying metastatic tumor cells and screening for antitumor agents, comprises hybridization to specific cDNA sequences |
| 03/28/2002 | DE10120095A1 Neue für das pknB-Gen kodierende Nukleotidsequenzen New coding for the PknB gene nucleotide sequences |
| 03/28/2002 | DE10112098A1 Neue für das chrA-Gen kodierende Nukleotidsequenzen New coding for the CHRA gene nucleotide sequences |
| 03/28/2002 | DE10109023A1 Neue für das gorA-Gen kodierende Nukleotidsequenzen New coding for the Gora gene nucleotide sequences |
| 03/28/2002 | DE10046870A1 Genetic manipulation of corynebacteria, useful for preparing fine chemicals, using a non-replicable vector that is not recognized as foreign |
| 03/28/2002 | DE10046400A1 Neuronal exprimiertes Protein und seine Verwendung Neuronal expressed protein and its use |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10045497A1 Neue für das ppsA-Gen kodierende Nukleotidsequenzen New coding for the ppsA gene nucleotide sequences |
| 03/28/2002 | DE10045496A1 Neue für das ptsi-Gen kodierende Nukleotidsequenzen New coding for the ptsI gene nucleotide sequences |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | DE10043470A1 Identification of cell-specific proteins, useful for development of highly selective therapeutic agents, e.g. for controlling migration of cancer cells |
| 03/28/2002 | DE10043011A1 New stabilized liposomes with stable internal skeleton derived from interfacial polymers, useful for enclosing and transporting pharmaceuticals or as micro-reactors for carrying out enzymatic reactions |
| 03/28/2002 | DE10042609A1 Verwendung von T-Proteinen zur differentiellen Charakterisierung und Therapie von Verletzungen und Tumoren des Nervensystems The use of T-proteins for differential characterization, and therapy of injuries and tumors of the nervous system |
| 03/28/2002 | DE10042598A1 Rekombinantes MVA mit der Fähigkeit zur Expression des HER-2/Neu-GENS The recombinant MVA with the ability to express the HER-2 / neu gene |
| 03/28/2002 | DE10042535A1 Verfahren zur verbesserten Herstellung und Isolierung von trans-Dihydroxy-Cyclohexadien-Carbonsäuren und/oder deren Folgeprodukte sowie ein dazu geeigneter genetisch veränderter Organismus Method for improving the production and isolation of trans-dihydroxy-cyclohexadiene-carboxylic acids and / or their derivatives, and to a suitable genetically modified organism |
| 03/28/2002 | CA2632702A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | CA2460014A1 Spas-1 cancer antigen |
| 03/28/2002 | CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin |
| 03/28/2002 | CA2423703A1 Use of a nucleic acid/pei complex |
| 03/28/2002 | CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | CA2423161A1 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |